applied microbiology international
applied microbiology international Company Information
Group Structure
View All
Industry
Activities of other membership organisations n.e.c.
Registered Address
salisbury house station road, cambridge, CB1 2LA
Website
sfam.org.ukapplied microbiology international Estimated Valuation
Pomanda estimates the enterprise value of APPLIED MICROBIOLOGY INTERNATIONAL at £2m based on a Turnover of £2m and 1x industry multiple (adjusted for size and gross margin).
applied microbiology international Estimated Valuation
Pomanda estimates the enterprise value of APPLIED MICROBIOLOGY INTERNATIONAL at £804.5k based on an EBITDA of £120.1k and a 6.7x industry multiple (adjusted for size and gross margin).
applied microbiology international Estimated Valuation
Pomanda estimates the enterprise value of APPLIED MICROBIOLOGY INTERNATIONAL at £29.9m based on Net Assets of £12.2m and 2.45x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Applied Microbiology International Overview
Applied Microbiology International is a live company located in cambridge, CB1 2LA with a Companies House number of 06462427. It operates in the activities of other membership organizations n.e.c. sector, SIC Code 94990. Founded in January 2008, it's largest shareholder is unknown. Applied Microbiology International is a established, small sized company, Pomanda has estimated its turnover at £2m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Applied Microbiology International Health Check
Pomanda's financial health check has awarded Applied Microbiology International a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
2 Weak
Size
annual sales of £2m, make it larger than the average company (£396.5k)
£2m - Applied Microbiology International
£396.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a faster rate (6.4%)
8% - Applied Microbiology International
6.4% - Industry AVG
Production
with a gross margin of 96.2%, this company has a comparable cost of product (96.2%)
96.2% - Applied Microbiology International
96.2% - Industry AVG
Profitability
an operating margin of 6% make it more profitable than the average company (2%)
6% - Applied Microbiology International
2% - Industry AVG
Employees
with 19 employees, this is above the industry average (10)
19 - Applied Microbiology International
10 - Industry AVG
Pay Structure
on an average salary of £49k, the company has a higher pay structure (£28k)
£49k - Applied Microbiology International
£28k - Industry AVG
Efficiency
resulting in sales per employee of £104.8k, this is more efficient (£53.5k)
£104.8k - Applied Microbiology International
£53.5k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (11 days)
1 days - Applied Microbiology International
11 days - Industry AVG
Creditor Days
its suppliers are paid after 9 days, this is quicker than average (34 days)
9 days - Applied Microbiology International
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Applied Microbiology International
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 133 weeks, this is average cash available to meet short term requirements (142 weeks)
133 weeks - Applied Microbiology International
142 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2%, this is a lower level of debt than the average (21.8%)
2% - Applied Microbiology International
21.8% - Industry AVG
APPLIED MICROBIOLOGY INTERNATIONAL financials
Applied Microbiology International's latest turnover from December 2023 is £2 million and the company has net assets of £12.2 million. According to their latest financial statements, Applied Microbiology International has 19 employees and maintains cash reserves of £627 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,992,000 | 1,607,000 | 2,052,000 | 1,587,000 | 1,520,000 | 1,549,000 | 1,648,000 | 1,449,000 | 1,334,338 | 1,362,981 | 1,243,694 | 1,229,678 | 1,247,672 | 1,175,341 | 1,434,154 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 118,000 | -51,000 | 854,000 | 987,000 | 123,000 | 53,000 | 348,000 | 172,000 | 182,061 | 131,558 | 223,791 | 278,341 | 285,426 | 366,027 | 457,121 |
| Tax | |||||||||||||||
| Profit After Tax | 118,000 | -51,000 | 854,000 | 987,000 | 123,000 | 53,000 | 348,000 | 172,000 | 182,061 | 131,558 | 223,791 | 278,341 | 285,426 | 366,027 | 457,121 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 118,000 | -51,000 | 854,000 | 987,000 | 123,000 | 53,000 | 348,000 | 172,000 | 182,061 | 131,558 | 223,791 | 278,341 | 285,426 | 366,027 | 457,121 |
| Employee Costs | 931,000 | 675,000 | 551,000 | 489,000 | 417,000 | 380,000 | 344,000 | 319,000 | 198,532 | 284,586 | 261,705 | 225,314 | 215,246 | 202,124 | 188,636 |
| Number Of Employees | 19 | 12 | 11 | 9 | 7 | 7 | 7 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,000 | 920,000 | 1,023,000 | 14,000 | 309 | 1,232 | 4,113 | 7,897 | |||||||
| Intangible Assets | 86,000 | 92,000 | |||||||||||||
| Investments & Other | 10,959,000 | 10,089,000 | 11,300,000 | 9,532,000 | 7,407,000 | 6,821,000 | 7,196,000 | 7,895,000 | 6,987,106 | 6,858,536 | 6,523,003 | 5,690,702 | 5,047,236 | 4,695,305 | 3,556,442 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 11,047,000 | 10,181,000 | 11,300,000 | 9,532,000 | 7,407,000 | 7,741,000 | 8,219,000 | 7,909,000 | 6,987,106 | 6,858,536 | 6,523,003 | 5,691,011 | 5,048,468 | 4,699,418 | 3,564,339 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 7,000 | 1,000 | 787,000 | 828,000 | 649,000 | ||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 786,000 | 910,000 | 1,360,000 | 823,000 | 850,000 | 32,000 | 55,000 | 56,000 | 628,545 | 623,136 | 587,039 | 607,773 | 652,663 | 692,936 | 675,982 |
| Cash | 627,000 | 791,000 | 677,000 | 1,007,000 | 2,010,000 | 482,000 | 478,000 | 356,000 | 156,574 | 199,786 | 182,939 | 97,065 | 165,476 | 288,059 | 275,351 |
| misc current assets | |||||||||||||||
| total current assets | 1,420,000 | 1,702,000 | 2,037,000 | 1,830,000 | 2,860,000 | 1,301,000 | 1,361,000 | 1,061,000 | 785,119 | 822,922 | 769,978 | 704,838 | 818,139 | 980,995 | 951,333 |
| total assets | 12,467,000 | 11,883,000 | 13,337,000 | 11,362,000 | 10,267,000 | 9,042,000 | 9,580,000 | 8,970,000 | 7,772,225 | 7,681,458 | 7,292,981 | 6,395,849 | 5,866,607 | 5,680,413 | 4,515,672 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 2,000 | ||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 242,000 | 290,000 | 260,000 | 303,000 | 195,000 | 66,000 | 105,000 | 128,000 | 107,966 | 82,601 | 91,311 | 114,276 | 228,797 | 238,748 | 112,045 |
| total current liabilities | 244,000 | 290,000 | 260,000 | 303,000 | 195,000 | 66,000 | 105,000 | 128,000 | 107,966 | 82,601 | 91,311 | 114,276 | 228,797 | 238,748 | 112,045 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | 6,000 | 13,548 | 6,645 | 9,450 | 11,697 | 10,673 | |||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 6,000 | 13,548 | 6,645 | 9,450 | 11,697 | 10,673 | |||||||||
| total liabilities | 244,000 | 290,000 | 260,000 | 303,000 | 195,000 | 66,000 | 105,000 | 134,000 | 121,514 | 89,246 | 100,761 | 125,973 | 239,470 | 238,748 | 112,045 |
| net assets | 12,223,000 | 11,593,000 | 13,077,000 | 11,059,000 | 10,072,000 | 8,976,000 | 9,475,000 | 8,836,000 | 7,650,711 | 7,592,212 | 7,192,220 | 6,269,876 | 5,627,137 | 5,441,665 | 4,403,627 |
| total shareholders funds | 12,223,000 | 11,593,000 | 13,077,000 | 11,059,000 | 10,072,000 | 8,976,000 | 9,475,000 | 8,836,000 | 7,650,711 | 7,592,212 | 7,192,220 | 6,269,876 | 5,627,137 | 5,441,665 | 4,403,627 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 3,000 | 19,000 | 14,000 | 1,000 | 309 | 923 | 2,881 | 3,784 | 5,149 | ||||||
| Amortisation | 4,000 | ||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | -118,000 | -449,000 | 537,000 | -27,000 | 31,000 | -64,000 | 178,000 | 76,455 | 5,409 | 36,097 | -20,734 | -44,890 | -40,273 | 16,954 | 675,982 |
| Creditors | 2,000 | ||||||||||||||
| Accruals and Deferred Income | -48,000 | 30,000 | -43,000 | 108,000 | 129,000 | -39,000 | -29,000 | 12,486 | 32,268 | -11,515 | -25,212 | -113,497 | 722 | 126,703 | 112,045 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -138,000 | 106,000 | 358,000 | -243,945 | |||||||||||
| Change in Investments | 870,000 | -1,211,000 | 1,768,000 | 2,125,000 | 586,000 | -375,000 | -699,000 | 907,894 | 128,570 | 335,533 | 832,301 | 643,466 | 351,931 | 1,138,863 | 3,556,442 |
| cash flow from investments | -870,000 | 1,211,000 | -1,768,000 | -2,125,000 | -586,000 | 237,000 | 805,000 | -549,894 | -372,515 | -335,533 | |||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 512,000 | -1,433,000 | 1,164,000 | 973,000 | -552,000 | 291,000 | 1,013,289 | -123,562 | 268,434 | 698,553 | 364,398 | -99,954 | 672,011 | 3,946,506 | |
| cash and cash equivalents | |||||||||||||||
| cash | -164,000 | 114,000 | -330,000 | -1,003,000 | 1,528,000 | 4,000 | 122,000 | 199,426 | -43,212 | 16,847 | 85,874 | -68,411 | -122,583 | 12,708 | 275,351 |
| overdraft | |||||||||||||||
| change in cash | -164,000 | 114,000 | -330,000 | -1,003,000 | 1,528,000 | 4,000 | 122,000 | 199,426 | -43,212 | 16,847 | 85,874 | -68,411 | -122,583 | 12,708 | 275,351 |
applied microbiology international Credit Report and Business Information
Applied Microbiology International Competitor Analysis
Perform a competitor analysis for applied microbiology international by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other small companies, companies in CB1 area or any other competitors across 12 key performance metrics.
applied microbiology international Ownership
APPLIED MICROBIOLOGY INTERNATIONAL group structure
Applied Microbiology International has no subsidiary companies.
Ultimate parent company
APPLIED MICROBIOLOGY INTERNATIONAL
06462427
applied microbiology international directors
Applied Microbiology International currently has 13 directors. The longest serving directors include Mr Oern Greif (Jul 2019) and Dr Emmanuel Adukwu (Jul 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Oern Greif | England | 61 years | Jul 2019 | - | Director |
| Dr Emmanuel Adukwu | England | 43 years | Jul 2020 | - | Director |
| Dr James Williamson | England | 35 years | Jul 2021 | - | Director |
| Dr Samantha Law | England | 50 years | Jul 2021 | - | Director |
| Dr Tajudeen Bamidele | Nigeria | 57 years | Jul 2022 | - | Director |
| Ms Catherine Rees | England | 64 years | Jul 2022 | - | Director |
| Dr Arpita Bose | United States | 44 years | Jul 2022 | - | Director |
| Professor Jack Gilbert | United States | 48 years | Jul 2022 | - | Director |
| Dr James Timmis | Germany | 41 years | Jul 2022 | - | Director |
| Professor Diane Purchase | England | 60 years | Jul 2023 | - | Director |
P&L
December 2023turnover
2m
+24%
operating profit
120.1k
0%
gross margin
96.2%
-2.28%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
12.2m
+0.05%
total assets
12.5m
+0.05%
cash
627k
-0.21%
net assets
Total assets minus all liabilities
applied microbiology international company details
company number
06462427
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
94990 - Activities of other membership organisations n.e.c.
incorporation date
January 2008
age
17
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
society for applied microbiology (September 2022)
accountant
-
auditor
HAYSMACINTYRE LLP
address
salisbury house station road, cambridge, CB1 2LA
Bank
BANK OF SCOTLAND
Legal Advisor
VEALE WASBROUGH VIZARDS LLP
applied microbiology international Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to applied microbiology international.
applied microbiology international Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for APPLIED MICROBIOLOGY INTERNATIONAL. This can take several minutes, an email will notify you when this has completed.
applied microbiology international Companies House Filings - See Documents
| date | description | view/download |
|---|
